Please join the Center for Multiple Myeloma for a free webinar for patients and families to learn about the most recent updates in muliple myeloma and Waldenstrom's macroglobulinemia including the impact of COVID-19 and vaccination.

Greetings to the entire WM community worldwide! Happy to have 2020 behind us, we now focus on COVID vaccines being widely available early in 2021. We all look forward eventually to being able to visit with our loved ones and share good times again.

When Peter DeNardis was diagnosed with Waldenstrom macroglobulinemia 17 years ago, he had no idea what his next steps would be. Follow along to hear the story of his diagnosis, treatment journey and where he is now, including all of the “peaks and valleys” that come along with navigating cancer. He also shares personal advice for those who are newly diagnosed with Waldenstrom macroglobulinemia.

Can New Drug Combinations Bring More Effective Treatment Options? New combination drug regimens are being studied for the treatment of Waldenstrom macroglobulinemia (WM). In this segment, Dr. Jorge Castillo, MD, of Dana-Farber Cancer Institute updates patients on the information presented at the recent American Society of Hematology (ASH) conference and suggests that Waldenstrom patients pay attention to the combination of ibrutinib and rituximab (INNOVATE Study), that have shown faster and deeper responses over time versus rituximab alone.

Dr. Edward Laane has completed his 3 events in the 2020 B.A.A. Virtual #finishSTRONG Challenge! His official times for the 5K, 10K, and Half Marathon are listed below.

Operational roles & functions of the Bing Center, as well as general WM questions regarding the current Pfizer, Moderna and AstraZeneca COVID-19 Vaccines. Also an update from the latest ASH conference. Recorded December 9, 2020.

Christian Buske, MD, discusses surprising findings from the 5-Year follow-up of a randomized phase 3 trial in patients with Waldenström’s macroglobulinemia receiving of ibrutinib plus rituximab or placebo plus rituximab.

Thank you so much for your interest in our recent Bing-Neel Syndrome support group meeting. Many of you were able to join the Zoom meeting live, while others volunteered to watch the recorded Zoom video [https://youtu.be/XQoqKzMshSI]. Many thanks to all who helped make this possible (the doctors, the IWMF office, The Bing Center for WM, the local support group members who helped plan, and all of you for your patience with me in pulling this together).

With a focus on the latest clinical trial data supporting individualized treatment strategies, this accredited, on-demand activity discusses best practices for addressing unmet needs in treatment selection, sequencing, and disease monitoring in Waldenström macroglobulinemia (WM).

We're pleased to announce that registration is now open for the 2021 Great Debates & Updates Conferences. Each meeting will cover the most critical updates occurring in the field, while incorporating a distinct focus on the latest advances and treatment options.